It was also found that the quotient CSF/serum IgG, expressed as a percentage of the CSF/serum albumin, was better in distinguishing patients with definite or suspected MS from those with other neurological disorders than the quotients IgG/albumin or IgG/total protein.
In normal individuals, immunoglobulin in the CSF is derived from the plasma by diffusion across the blood/CSF barrier (see Schultze and Heremans (1966) Chapter 3 for review). Rosenthal and Soothill (1962) have shown that the quantity of this CSF immunoglobulin is dependent on the serum immunoglobulin concentration, the molecular size of the immunoglobulin, and the permeability of the blood/ CSF barrier. Thus for healthy individuals IgM is totally excluded from the CSF owing to its large size and low plasma concentration but may be present in conditions in which a gross defect in the Received for publication 10 May 1976 blood/CSF barrier has occurred or where a high serum level exists.
However, in the last two decades a considerable amount of clinical and experimental evidence has accumulated which strongly suggests that immunoglobulin may be additionally synthesized in the central nervous system (CNS) in certain demyelinating and infectious neurological diseases (reviewed by Tourtellotte (1970) ).
The CNS-produced immunoglobulin may be indirectly assessed by measuring the CSF immunoglobulin. However, in doing this it is necessary to correct for the permeability of the blood/CSF barrier in order to account for the immunoglobulin derived 1105 from the plasma. Tourtellotte (1970) and others have shown that the permeability of the blood/CSF barrier is accurately reflected by the CSF total protein or albumin level, and thus most investigators have related the absolute CSF immunoglobulin level to the CSF total protein or albumin level in order to derive a relative immunoglobulin concentration. If this relative concentration (or immunoglobulin quotient) is raised, this has been taken to indicate the local synthesis of immunoglobulin within the CNS.
The aim of the present study has been to measure the CSF immunoglobulin/albumin quotient in patients suffering from a variety of neurological disorders and to compare groups of patients with demyelinating, infectious, and polyneuritic diseases with the remaining patients. An endeavour has also been made to find which CSF quotient, out of several which have been described, is best at distinguishing the different groups. In addition, in certain patients the IgG/albumin quotient has been compared with the CSF kappa/lambda ratio and the CSF measles, mumps, and herpes simplex antibody titres to see the relationship between these measurements and to determine whether a further refinement in the separation between these diagnostic groups can be obtained.
Patients
The CSF was obtained from 355 patients suffering from a variety of neurological disorders. At the end of the period of study the clinical and laboratory details were reviewed from the case notes and a comparison was made with the CSF findings.
There were 236 patients who formed the neurological control group. They consisted of 92 females and 141 males (3 were unknown) and had an average age of 46-4 years. Thirty-eight of these patients had cerebrovascular disease, 14 (1972) . Thus patients with definite MS had evidence of multiple sites of CNS involvement associated with a history of a previous acute neurological episode followed by improvement and then one or more relapses. There were 23 females and 13 males in this subdivision; their mean age was (range 17-60) years, the mean duration of the disease was 5-8 years (range 1 week-28 years), and the mean number of neurological episodes was 3-1 (range 2-6). There were 25 females and 22 males with probable or possible MS. The mean age was 40-7 (12-64) years, the mean duration 3-7 years (1 week-23 years), and the mean number of attacks 1-8 (1-8). For both MS groups over 80% of the patients were studied during an active phase of the disease. The remaining patients were either in clinical remission or had the chronic progressive form of the disease.
Twenty-four patients suffered from a CNS infection. Patients were not included in this category unless an infectious agent was positively identified or strongly implicated. Nine patients had HSVE, the diagnosis being proven by viral isolation from brain biopsy or CSF, positive immunofluorescence, or a rising titre to herpes simplex virus (HSV) in both the serum and CSF. Five patients had bacterial meningitis, four patients had neurosyphilis, two patients had tuberculous meningitis, two patients had herpes zoster meningoencephalitis, and one patient each had SSPE and a cerebral abscess.
The remaining 12 patients had a polyneuropathy, including four with characteristic features of the Guillain-Barre syndrome.
Methods

CEREBROSPINAL FLUID
CSF was obtained by the lumbar route in all patients. These specimens consisted of the majority received by the laboratory over a one-year period. However, seven specimens from patients with HSVE had been collected and stored at -20°C over an eight-year period. Specimens of CSF were eliminated if heavily bloodstained (> 2000 red blood cells/mm3). The CSF cell count was routinely performed and the cells were separated by gentle centrifugation. The total protein was then measured and the specimens were stored at -20°C for future protein estimation. This was performed in large batches within six months of storage.
Serum was available for study from 62 of the patients. It was collected at the time of the lumbar puncture and studied simultaneously with its corresponding CSF.
CSF TOTAL PROTEIN
The CSF total protein was measured using a modification of the U-V spectrophotometric method of Waddell (1956 (Weeke and Krasilnikoff, 1970 Six patients had a quotient greater than the M + 2SD. Two of these had long-standing dementia, and in one an elevated K/A ratio (vide infra) and a mild CSF pleocytosis (6 lymphocytes/mm3) were also found. A third patient had a low CSF albumin but a normal CSF IgG concentration.
Of the 10 patients with quotients less than the M -2SD (6-9%, fig 1) , two were children with hydrocephalus. A third infant of 2 months of age was also noted with a low quotient and predictably had low levels of serum and CSF IgG. The remaining seven patients had a variety of unrelated diseases.
The M + 2SD of the IgG/albumin quotients of a group of 36 patients suffering from myelographically defined cervical spondylosis with myelopathy or lumbar disc herniation was 14-5 + 10-2%. If 24-7 % is taken as an upper limit for this latter group, this is of the suspected MS patients had CSF mononuclear leucocyte counts in excess of 5 cells/mm3. A significant correlation was seen between this cell count and the IgG/albumin quotient when both MS groups were combined (r = 0-38, p = 0-01) but not for the definite MS group taken alone. Significant correlations were also seen for both groups combined between the IgG/albumin quotient and the duration of the disease (r = 0-22, p = 0 05), and the reciprocal of the albumin level (r = 0-24, p = 0W04). These correlations were not significant, however, in the definite MS group alone. No correlation was observed with the age of the patients in either group or in both groups combined.
Patients with CNS infection Several CSF specimens from patients comprising the CNS infection group had elevated IgG/albumin quotients ( fig 1) . Of interest was the finding that 6/9 patients with proven HSVE had elevated quotients. Of the three CSF specimens with normal quotients, one was from a patient who had survived the encephalitic episode for over a year while another was from a patient whose encephalitis had been present for only two days. The clinical details of the third patient were unobtainable. Recent evidence has shown a preferential increase in the kappa light chain subclass of CSF IgG in some patients with MS (Zettervall and Link, 1970 (MacCallum et al, 1974) . These viral studies have been reported elsewhere and will not be further discussed (MacCallum et al, 1974) . The IgG/albumin quotient was elevated in six of the antibody positive patients. In addition, two of the remaining three patients had high normal quotients of 27-5% and 25-6% (see fig 1) . In the former patient an abnormal total protein of 109 mg% was recorded while in the other the total protein was normal. The CSF/serum antibody titre was 1:16 in the former patient and it was not measured in the latter.
No antibody against HSV was detected in any of the CSF specimens from the neurological control group while two patients with MS had antibody against HSV (vide supra)..
One patient with neurosyphilis showed a CSF antibody titre to both HSV (1:16) and measles virus (1:4). The CSF protein in this patient was 85 mg% and 25 % of this was IgG.
ANTIBODY AGAINST MUMPS VIRUS
The CSF from 17 patients with MS and from 16 patients with other neurological disorders was examined for mumps antibody. No antibody was detected in any of these specimens. (Kabat et al, 1950; Harter et al, 1962; Schneck and Claman, 1969; Riddoch and Thompson, 1970; Link and Muller, 1971) . However, it is difficult to compare or contrast individual studies due to the different diagnostic criteria and CSF quotients used in the assessment of the patients.
In many studies a small number of patients with presenile dementia, with or without extrapyramidal features, have been noted to show elevations of the relative CSF IgG concentration (Yahr et al, 1954; Riddoch and Thompson, 1970; Link and Muller, 1971; Skrabanek et al, 1973) . In the present study two such patients were observed. The clinical features of one patient were non-specific while the pathological examination of the CNS in the second showed only a cerebral infarct. In neither patient was the serum examined for the presence of a polyclonal or monoclonal increase in IgG which would also increase the CSF IgG/albumin quotient (Riddoch and Thompson, 1970) . It would be of interest to know whether such patients have undiagnosed MS, which occasionally gives rise to a presenile dementing process (McAlpine et al, 1972) ; a CNS infection such as HSV, which has been suggested to be a cause of early dementia (MacCallum, et al, 1974) ; or whether these patients suffer from another disorder.
The IgG/albumin quotient was elevated in 53 % of the patients with definite MS as compared with 28 % of the patients with suspected MS. The difference between these groups could be due to the inclusion of patients in the latter group who will ultimately turn out to have another disease. But, alternatively, since many of these suspected MS patients were suffering from an initial acute neurological episode, this might suggest that the IgG/ albumin quotient is not elevated in the early stages of MS with the same frequency as is seen for established MS. Follow-up and serial estimations of the IgG/albumin quotient in these suspected MS patients will help to clarify this problem. However, Glasner (1974) has noted a rise in the relative CSF IgG concentration in the first few months after the initial attack in the majority of 96 patients with MS. The relative IgG concentration appeared to stabilize after an interval of one year from the initial episode.
One-third of the definite MS patients in this study had an elevated kappa/lambda ratio when compared with the neurological control group. This figure is a little lower than the 53% obtained by Link and Muller (1971) . These investigators also measured the same ratio in the serum of their patients and found no difference between the groups. They therefore concluded that the increase in the kappa/lambda ratio in the MS CSF was probably due to a disproportionate increase in the quantity of the IgG molecules with light chain of type kappa. Why this should occur is not known.
Viral antibody studies were performed in many of the MS patients. The increased serum title of measles antibody in a group of 16 patients with MS when compared with a group having other neurological disorders, is in accord with previously reported studies (Adams and Imagawa, 1962; Haire et al, 1973) . Norrby et al (1974) have studied measles titres in serum and CSF in 30 patients with definite MS and in 30 patients with other neurological disorders. They found haemagglutination-inhibiting and/or nucleocapsid complement-fixing measles antibody in 13 MS CSF specimens in contrast to their neurological control group in which only two specimens were positive. They also found a significant reduction in the serum/CSF ratio of these measles antibodies in 12 of the 30 MS patients but did not see any reduction in their neurological disease group. These investigators conclude that antibody against measles virus is produced in the CNS of some MS patients.
In the present study the examination of 53 CSF specimens from patients with definite or suspected MS revealed antibody in 11. Seven of these antibody positive patients had a normal IgG/albumin quotient. In the study of Norrby et al (1974) four of their MS patients had a normal IgG/total protein quotient and one of these had a significantly reduced serum/CSF ratio of measles antibody. Both these findings therefore suggest that some patients with MS may have CNS production of measles antibody without any elevation of the relative concentration of CSF IgG. The assessment of CSF measles antibody or, more importantly, the serum/ CSF measles antibody titre may be useful in detecting some patients with MS who have normal IgG/ albumin quotients. Rosenthal and Soothill (1962) It was of particular interest that 6/9 patients with herpetic encephalitis had marked elevations of the IgG/albumin quotient. These six specimens of CSF were all obtained between the 12th and the 200th day of the illness. Normal quotients were seen in one patient at the second day of the illness and in another who had survived for longer than one year. A rising quotient was also observed in one patient in the early stages of the disease and a falling quotient in another (over a five-month period). These observations are reminiscent of the rise seen in the CSF titre of antibody to HSV in the first two weeks of the disease and the slow decline over the following months (MacCallum et al, 1974) .
A similar increase in CSF IgG in HSVE has been previously noted by von Welsum and van der Helm (1970), Rappel et al (1971) , and Link and Muller (1971) , but only in the latter study have the CSF immunoglobulins been measured quantitatively.
Elevation of the IgG/albumin quotient was also found in the present study in cases of neurosyphilis SSPE, cerebral abscess, and meningitis, as has been previously described by others (Yahr et al, 1954; Link and Muller, 1971) .
Patients with polyneuropathies, including those with the characteristic features of the GuillainBarre syndrome, have been recorded in which a relative increase in the CSF IgG or gamma globulin has occurred (Harter et al, 1962; Laterre et al, 1970; Link, 1973) . In general, the frequency of occurrence is low and compares with the 17 % seen in the present study. The nature or cause of the selective increase of CSF IgG is unknown. Link (1973) has also described monoclonal bands occurring in the serum of 8 out of 10 patients with the Guillain-Barre syndrome similar to that seen for one patient in the present study. The origin and function of this monoclonal immunoglobulin are unknown.
The measurement of CSF IgA and IgM was not of great use in the comparison of the various groups. IgA and IgM were relatively increased in some patients with CNS infection but were too few in numbers in these groups for one to decide whether this was a constant feature. It appeared that IgA and IgM were not included in the CNS antibody response seen in MS, and this finding is in keeping with the conclusion of other investigators (Link, 1967; Link and Muller, 1971) .
Five patients out of 16 tested with CNS infections showed an elevated CSF K/A ratio while 2/5 patients with polyneuropathy also showed this increase. This is in contrast to the findings of Link and Muller (1971) where none of the 39 patients with CNS infections showed any change in this ratio.
The present results show that alterations in the K/A ratio are not specific for MS.
In conclusion, it is considered that the estimation of the relative concentration of CSF immunoglobulin, together with other methods of CSF immunoglobulin analysis (including K/A ratio, viral antibody studies, and electrophoresis), will supplement each other in the endeavour to detect pathological production of immunoglobulin in the CNS in certain neurological conditions. We should like to thank the consultants and staff of the Neurology Department, Churchill Hospital for allowing us to study their patients. PJR-T is a re-cipient of the Senior Hulme (Overseas) Scholarship, Brasenose College, Oxford. Mrs A. Houghton gave much appreciated secretarial assistance.
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